These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 9735549)

  • 21. [Open question to those responsible for the measles-mumps-rubella vaccination program].
    Gaillet RP
    Rev Med Suisse Romande; 1988 Aug; 108(8):711-6. PubMed ID: 3187286
    [No Abstract]   [Full Text] [Related]  

  • 22. The national measles and rubella campaign--one year on.
    Commun Dis Rep CDR Wkly; 1995 Nov; 5(45):237. PubMed ID: 8541943
    [No Abstract]   [Full Text] [Related]  

  • 23. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland.
    Paunio M; Virtanen M; Peltola H; Cantell K; Paunio P; Valle M; Karanko V; Heinonen OP
    Am J Epidemiol; 1991 Jun; 133(11):1152-60. PubMed ID: 2035518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Australian Measles Control Campaign, 1998.
    Turnbull FM; Burgess MA; McIntyre PB; Lambert SB; Gilbert GL; Gidding HF; Escott RG; Achat HM; Hull BP; Wang H; Sam GA; Mead CL
    Bull World Health Organ; 2001; 79(9):882-8. PubMed ID: 11584738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catch-up immunization programs will eliminate measles threat for most schoolchildren.
    Rafuse J
    CMAJ; 1996 May; 154(10):1567-8. PubMed ID: 8625011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles, mumps, rubella, and varicella.
    Isaacs D; Menser M
    Lancet; 1990 Jun; 335(8702):1384-7. PubMed ID: 1971671
    [No Abstract]   [Full Text] [Related]  

  • 28. [35-year measles, mumps, rubella vaccination assessment in France].
    Reinert P; Soubeyrand B; Gauchoux R
    Arch Pediatr; 2003 Nov; 10(11):948-54. PubMed ID: 14613687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
    Heath TC; Burgess MA; Forrest JM
    Commun Dis Intell; 1998 Aug; 22(8):157-8. PubMed ID: 9735550
    [No Abstract]   [Full Text] [Related]  

  • 31. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measles-rubella vaccination campaign].
    Infirm Fr; 1984 Jan; (251):23-6. PubMed ID: 6561159
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles, measles vaccination, and Crohn's disease. Crohn's disease has not increased in Finland.
    Pebody RG; Paunio M; Ruutu P
    BMJ; 1998 Jun; 316(7146):1745-6. PubMed ID: 9652932
    [No Abstract]   [Full Text] [Related]  

  • 34. Measles, measles vaccination, and Crohn's disease. Second immunisation has not affected incidence in England.
    Miller E; Waight P
    BMJ; 1998 Jun; 316(7146):1745. PubMed ID: 9614036
    [No Abstract]   [Full Text] [Related]  

  • 35. [Response to: "Open question to those responsible for the MMR vaccination program" by Dr. R. Ph. Gaillet].
    Méan F
    Rev Med Suisse Romande; 1988 Oct; 108(10):907-10. PubMed ID: 3206040
    [No Abstract]   [Full Text] [Related]  

  • 36. Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA.
    Groves FD; Gridley G; Wacholder S; Shu XO; Robison LL; Neglia JP; Linet MS
    Br J Cancer; 1999 Sep; 81(1):175-8. PubMed ID: 10487630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles-mumps-rubella vaccine. Advance in immunization.
    Barkin SZ; Barkin RM
    Rocky Mt Med J; 1975 Jun; 72(6):247-50. PubMed ID: 1145029
    [No Abstract]   [Full Text] [Related]  

  • 38. Need for measles revaccination.
    John TJ
    Indian Pediatr; 1998 Aug; 35(8):789-91. PubMed ID: 10216577
    [No Abstract]   [Full Text] [Related]  

  • 39. Measles, mumps and rubella. The new MMR.
    Golding AM
    Public Health; 1988 Nov; 102(6):517-8. PubMed ID: 3231693
    [No Abstract]   [Full Text] [Related]  

  • 40. [Guidelines for protective immunization. Observations on the new recommendations of the Federal Health Department].
    Hitzig WH
    Schweiz Rundsch Med Prax; 1987 Mar; 76(13):340-3. PubMed ID: 3576033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.